Medco traded at a ten percent discount to the deal terms all day Thursday, reflecting skepticism that the U.S. government will let the deal happen. I don't see why. The government favors concentration in the health sector.
Read my latest column at Forbes.com: The Apothecary.
Research and commentary from a former senior executive in the U.S. Department of Health & Human Services
No comments:
Post a Comment